Cic Mining Share Chat (CICC)

All our CIC investments are dead ducks.

SB liked to fob off investors by promising Innomed shares to people who emailed him. He once promised me some Innomed warrants after I pointed out a mistake on a CIC website.

He can still brag about how he runs a medical device company to people he meets in some fancy hotel in Thailand and look like a responsible businessman.

Innomed is basically CIC imo. BoD, SB designing the product blah blah blah!!

Think you will find another company was duped into thinking Cicc was the major corporation who floats many companies in a timely manner around the world.

Innomed looks as if it’s got sucked in spent Cicc money and have no way of getting out except through a listing.

In the meantime for 12 years we have seen nothing.

Iam sure Stuart living a life style he is a custom to.

Write your investment off with the tax man

Again today, on the 2nd May, 12 years ago, Mr Stuart Bromley delisted CIC (Eleven-million-pound company) from the Aim market promising to re-list within a few months.

Shareholders have not seen a penny from Mr Bromley in all this time. Many have passed like Share shark etc.

I hear that Mr Bromley had been made an honorary member of the Magic Circle for

his extraordinary feat and ability to make this money vanish without trace. !!!

He has also recently been give a medal for long service and his "special illusion" during this last year - having manage to get most CIC investors on the edge of their seats with Innomed Tec, with "one puff of smoke and a flash of a mirror" he made it vanish from sight.

Is Harleygreen a politician.?

His idea to solve the overcrowding in our prisons by releasing all the burglars as they are now " innocent" as all victims "could have moved their belongings" the day before they were burgled !!!

Paid him nothing for years since we delisted, he says around 5 months ago that he listed me for shares in the new listed company but got one email confirming but nothing since

So who is getting scammed now? Anyone lose any money recently? Anyone paid Stuart anything? We all had the choice to sell up before delisting...when was that 10years ago?

The silence is damning all right but I've not lost any more money than my original modest stake and apparently have some shares in a "private" company.

Must have cost a few quid to organise the drs's and send them .Why bother?

And what relevance is that to long suffering CICC holders who have seen zero return with nothing even on the horizon. There has been no explanation given as to why Innomed hasn’t listed. Billy used to keep people informed but now I guess they can’t think of any more excuses. It’s been nothing but hot air from start to finish

This is working https://www.securitisation.com/

Has anybody close to SB managed to find out what’s going on? In my mind there has been nothing but lie after lie and I don’t see anything happening here. It’s been one big scam. Should have heeded the warning about the Boy Scouts getting mugged

Long history of scam…

REad it mac

"fluid dynamics" I thought he was graduate in mining.. .. Jees . Nothing about the listing. Not a sausage.

CORPORATE UPDATE

Released 15:08:29 12 March 2026

RNS Number : 4634W

InnoMed Tech Ltd.

12 March 2026

Innomed Tech Ltd.

Corporate Update

Innomed Tech Ltd. (BC, Canada) (the "Company") is pleased to provide the following corporate update.

PureFlowCath Catheter to Market Development

The Company has completed the preliminary design and specification of the PureFlow Catheter. The initial

focus will be to obtain European certification. Save for any major unforeseen technical issues, the objective

is to reduce the development-to-market time in Europe from the initial estimate of 5 years to

approximately three years.

The EU patent is secured with CIC Fund Securitisation SA, Luxembourg. CIC Fund Securitisation SA,

Luxembourg, which is contracted to the Company to manage the EU CE certification process.

Three Luxembourg health and scientific institutes are being engaged through CIC Fund Securitisation SA to

assist with the CE certification process. The USA FDA approval process will follow the work in Luxembourg

to leverage development while reducing costs and time.

Board Restructuring.

With the Company's focus moving to the development of the PureFlowCath Catheter, Dr. Matthew

McIntyre, the inventor of the PureFlowCath Catheter, has been appointed to the board. Dr. Matthew

McIntyre and Dr. Marshall Walker will oversee the medical sciences required for the PureFlowCath

Catheter development.

Stuart J. Bromley of CIC Securitisation SA, a former process engineer with a major in fluid dynamics, will

conduct the Bio Medical Engineering design for the complex biofilm flushing and catheter fluid dynamics

required for the PureFlowCath Catheter, and in association with Dr. Matthew McIntyre and Dr. Marshall

Walker, work on the medical sciences required in the design.

The Company will make further director appointments to provide the expertise it requires for its

development.

EU Grant Application

The Company, through CIC Fund Securitisation SA, Luxembourg, and the formal appointment of

Luxembourg health and scientific institutes, qualifies and is eligible to apply for significant European grants

for the CE certification process. Accessing this funding will allow the Company to develop new catheter

patent applications and products from the expertise gained from the development and design of the

PureFlowCath Catheter. Mr. Joshua Peters of CIC Fund Securitisation S.A. will head the grant application

process supporting Innomed Tech’s CEO, Mr. Robert Rhodes.

TSX Venture Listing Process

The Company will advise in more detail on progress in a future announcement.

Mr. Robert Rhodes

Mr. Stuart J. Bromley

WWW.Innomedtec.com

Innomed Tech Ltd.

rrhodes@innomedtec.com

+33 (0) 788 26 80 35

Bromley@CICCapital.com

The Company's first medical device development subsidiary, PureFlowCath, is

Seems that Stuart has not retired and is multi-talented.

"Stuart J. Bromley of CIC Securitisation SA, a former process engineer with a major in fluid dynamics, will

conduct the Bio Medical Engineering design for the complex biofilm flushing and catheter fluid dynamics

required for the PureFlowCath Catheter, and in association with Dr. Matthew McIntyre and Dr. Marshall

Walker, work on the medical sciences required in the design."

Corporate update issued today

Macnai. Fair enough but this has taken two years too apparently fail. What chance other companies?

The US Nasdaq market is full of medical-related companies spending vast amounts of money and taking many years to find success.

If Innomed' s product is good enough to attract backers, maybe there is some hope.

So far nadda.

Whatever happened to all the other deals Stuart said he was working on?

I think Stuart has retired and lost interest.

Not been a dicky bird from the company or Stuart lately. The listing date was extended and did not list before the time limit in Early March. So the company might be ok but has real value to shareholders. They have limited finances and could have done with Listing.

Not sure why you say this has failed? Has there been an update from the company?

Stuart has not had a penny out me for ten years..It cost money to organise and allocate the shares to shareholders of CICC. even the postage from Luxembourg was not cheap. Hardly a scam, to what end? A failure for sure. Not sure where INNOMED goes from here.. or why the application failed before the expiry date.

It’s just been one big scam. Just surprised they bothered to drag it out as long as they have

Stuart Not replying to emails anymore. What was the point of sending out the DRS's..?

I have emailed him. I'll let you know if he replies... Don't hold your breath.

Disappointing. anyone heard from Stuart? anyone emailed him?

Not seen any news and I'm pretty sure today is last day for listing unless there is an extension..?

Macnai, you heard anything? Cutting it fine..Another false dawn?

Rob

March the 2nd. IE two working days away, is the deadline for listing. Stuart said it would be met. Not long to wait now too see! No idea if any further extension would be granted. Any other info you have would be welcome.

Johnny , just saw the RNS on lse

With the confirmation (a prompt reply) by Stuart that the Listing deadline will be met I'd like to know if anyone else has a different Number notified to them?

Both Mac and I seem to have the same number ie 16,000 shares.

Still no idea of initial float price. Just a guess based on Warrant redemption price.

Thanks for all the updates etc. Much appreciated.

havegun, are you signed up for reach updates or did you search manually?

Are we to receive "specie" in this company as well? as per the original Model conceived many years ago? any ideas anyone?

Still no listing news re INNOMED...yet!

Reach

Non Regulatory Reach Announcement

Share this article

Debt Finance Facility to Dynex

Released 09:45:21 21 January 2026

RNS Number : 7807P

CIC Capital Ltd

21 January 2026

Debt Financing Dynex

CIC Capital Ltd, Transaction Advisor to Dynex Holding Establishment. (Liechtenstein) ("Dynex") is pleased to announce the securitised debt finance for Dynex.

Dynex has executed a debt financing agreement with CIC Fund Securitisation S.A. (Luxembourg) for a pre-IPO financing facility of up to EUR 55,000,000, subject to the terms and conditions of the financing agreement.

The facility bears compound interest at a rate of 12.20% per annum over a five (5) year term, with interest payable at maturity. The financing has been structured as a convertible debt instrument, pursuant to which the outstanding principal and accrued interest may be redeemed into equity of Dynex upon the completion of a public listing on a designated stock exchange, subject to the terms of the financing agreement and applicable regulatory approvals. The financing is subject to a Luxembourg regulatory and administrative fee of 4.2% over the five-year term, payable annually in advance.

The proceeds of the financing facility, together with Dynex's existing cash resources, are intended to be used to support the ongoing advancement of the company's proprietary Quantum-as-a-Service (QaaS) technologies, the expansion of its operational and commercial capabilities, expanding its market adoption, and a regulated public listing.

Transaction Advisor and Public Listing Sponsor

CIC Capital Ltd. (Canada) has been appointed Transaction Advisor and Listing Sponsor to Dynex for a regulated public listing on a designated stock exchange.

Stuart J. Bromley Bromley@CICCapital.com

CIC Capital Ltd. -Transaction Advisor

+33 788 26 80 35 (Paris)

CIC Capital Ltd is a corporation within the Global CIC Group Corporations.

About Dynex Holding Establishment

Dynex develops quantum-driven solutions at scale through its proprietary Quantum-as-a-Service (QaaS) technology, with an emulation of up to 1 million algorithmic qubits and, with Dynex's quantum-driven neuromorphic chip 'Apollo' real-time compute of up to 10,000 physical p-qubits. Through its unique cloud-based qubit-agnostic platform architecture, it enables accessibility to quantum-driven computing to solving real-world problems at scale. Dynex focus is to maintain its position at the forefront of quantum technological innovation and acceleration toward mainstream adoption of its quantum-driven solutions.

Yes it is interesting..Long been interested in the sub molecular world and Quantum mechanics in particular. Not that I or anyone really understands it.

Interesting that a lack of real understanding does not stop the use by innovative companies.

Hi Mac, and all holders.

#

I enquired of Stuarts health and the Listing deadline via email.

He informs me

"Yes they will meet the deadline."

Good enough for me.

Https://dynex.co/

Dynex is a leader in Quantum-as-a-Service (QaaS) technologies, providing a platform that uses neuromorphic quantum computing emulations on a decentralized network of GPUs to solve complex real-world problems. Unlike traditional quantum computers that require specialized hardware and cryogenic temperatures, Dynex uses a proprietary Proof-of-Useful-Work (PoUW) algorithm (DynexSolve) to run computations that mimic quantum behavior, such as superposition, entanglement, and tunneling.

Core Technology Components

Neuromorphic Computing: The technology simulates brain-like, analog, and quantum behavior to solve optimization, simulation, and machine learning tasks.

Algorithmic Qubits: The platform can simulate up to 1 million algorithmic qubits.

The "Apollo" Chip: Dynex is introducing the Apollo neuromorphic chip, which supports up to 10,000 physical p-qubits (physically emulated qubits) and operates at room temperature.

Decentralized Network: The platform runs on a network of over 150,000 GPUs.

Dynex SDK: A Python-based software development kit allows users to integrate with existing frameworks like Qiskit, Cirq, and TensorFlow.

Key Advantages

Performance & Scalability: Dynex has achieved Q-Scores over 15,000, surpassing many existing quantum computers. It is designed to handle large-scale, real-world problems that currently exceed the capabilities of noisy, small-scale quantum hardware.

Energy Efficiency: By using GPUs, the platform is significantly more energy-efficient than traditional, hardware-heavy quantum systems, without requiring cryogenic conditions.

Cost-Effectiveness: It offers up to 90% lower costs compared to traditional supercomputers and quantum platforms.

Ethical Focus: The ecosystem, guided by the Dynex Moonshots Foundation, includes an ethical committee to review and monitor computational jobs, with all data recorded on a layer-one blockchain.

Applications and Use Cases

Dynex's QaaS is applied in various industries, including:

Automotive/Aerospace: Advanced Computational Fluid Dynamics (CFD) and vehicle design.

Pharmaceuticals: Protein and RNA folding for drug discovery.

Finance: Portfolio optimization and risk analysis.

Artificial Intelligence: Enhancing machine learning models and training, including the use of "Quantum Transformers".

Logistics: Multi-vehicle routing and scheduling.

Recent Developments (2024-2025)

Transition to Institutional Status: In September 2025, Dynex announced a transition to a security token framework, allowing for compliance with institutional capital-market standards.

Partnerships: Strategic partnerships have been established with SilverStone & Partners, InCor (Heart Institute at the University of São Paulo), and Ubuntu Tribe.

Recognitions: Named 2024 Technologist of the Year by Fast Company and received the BIG Innovation Award 2025.

The company is moving toward full-stack solutions, combining its software emulation with the upcoming Apollo hardware to bridge the gap between c

Not sure mate. Stuarts had mine for well over 13 years . Stuart forwarded mine to Billy (innomed) Not spoken to Stuart for years .No need really, nothing happening. He did send me a very long biographical account once, many years ago about his Mining in China and how he made his dosh.

I had like many of us thought it was all over. Put it down to experience but here we are again. If we list , there may be more specie. The concept prven and all that.

I''d email Stuart and give him any previous email addresses you had. Failing that , Email him to find out what time zone he is in and ring him business hours. He could be in Scotland or far East.

Harley - will they retain our email address or anything from historic ownership? I’ve emailed numerous times over the years and only ever had a reply in the immediate aftermath of delisting.

Re those warrants. Seems cheap but there will be no complaints if they take shares instead of demanding re payment. A reasonable ration/gearing for a start up. They have EU approval , USA will be important.

Hopefully this funding does the trick with only 6weeks to go to the deadline.

As regards listing, we seem to be getting there. Part of the requirements was the issue of shares to us. This finance deal seems to be vital too.

"Key progress points and next steps include:

Conditional Approval: Received in June 2025, with a deadline to meet final requirements by March 2nd, 2026.

Documentation: The final Non-offering Long Form Prospectus has been filed with the British Columbia Securities Commission and is available on the SEDAR+ website.

Working Capital: The company recently signed a new debt finance agreement for an additional €5.5 million in January 2026 to support its operations and business plan.

Trading Date: A possible trading date will be announced to shareholders once the TSXV grants final approval.

While the conditional approval is a significant milestone, success in the final listing depends on InnoMed Tech Ltd. successfully addressing all outstanding matters to the satisfaction of the TSXV within the specified timeframe. "

Found this which covers it I guess.

"Innomed Tech Ltd. is not formally listed on the London Stock Exchange (LSE) but is in the process of seeking a listing on the TSX Venture Exchange (TSXV). The company uses the RNS (Regulatory News Service) for disseminating information through RNS Reach, a service that allows unlisted and foreign-listed companies to reach a professional UK financial audience.

This allows the company to:

Deliver non-regulatory news to investors, analysts, and the media.

Ensure broad dissemination of corporate and product information to an international audience, including over 2 million professional terminals and databases worldwide.

Gain visibility within the UK financial community in anticipation of potential future listings or investment.

Innomed Tech Ltd. has been providing regular updates through RNS as it works to meet the final requirements for its conditional listing on the TSXV by the deadline of March 2,"

Bromley@ciccapital.com

Thanks

Used the same email address on here.

Got a reply next day.

I refer you to my earlier reply. Those with a minimum seem to get 16,000 shares. As I said Macnai has far more CiCC than me. He got sent the same ...16,000.

So no "split" as far as I can see. Mac may have other knowledge.

He may also help with the email address. As far as knew it has not changed?

Hi

What’s the split

Ie for every 1000 Cicc shares you get say 100 Innomed shares

Hiya BU

Like I said ,no split as such. I got one tranche of 5,000 followed by another of 11,000. 16,000 in all and Macnai has received the same amount despite having more CICC shares than me. A lot more.

Good to see Stuart is still communicating. I too have some CICG but not much hope there I fear.

Did Stuart mention anymore companies in the pipeline? This listing has taken a long time but maybe the next ones will be quicker.

Innomed Tech Ltd.

Corporate and Debt Financing Update

Innomed Tech Ltd. (BC, Canada) (the “Company”) is pleased to announce that on January 8, 2026 the Company signed

a debt finance agreement with CIC Securitisation S.A. (Luxembourg). CIC Fund Securitisation S.A. previously provided

debt financing facility to the Company in the amount of €5,000,000 of which €4,600,000 was drawn down and together

with interest accrued, was redeemed and converted into equity in the Company in 2023.

CIC Fund Securitisation S.A. is providing an additional €5,500,000 unsecured five year debt financing facility through

Compartment Equity Trust Fund at 12.50% compound interest per annum, and paid on the earlier of the maturity date

or the date the debt notes are redeemed for equity in the Company at US$0.08 per common share with a full warrant

for each common share issued, exercisable at US$0.08, exercisable in part or whole on or before three years from the

date of issuance.

CIC Securitisation S.A. may elect to redeem the debt notes and any outstanding interest into equity in the Company

before the maturity date, subject to Canadian regulatory and TSX-V requirements. The debt finance transaction has

been structured to meet compliance with stock exchange policies, including no single investor holding more than 9.50%

of the issued and outstanding capital of the Company on a fully diluted basis upon the redemption of debt to shares and

warrants.

The finance will be subject to a 4.20% Luxembourg regulatory administrative fee payable over five (5) years in equal

instalments, on each 12-month anniversary following the first drawdown, on the total amount of the debt facility. In

addition, commissions to CIC Fund Securitisation S.A. of 4.50% of debt finance will be deducted from funds on each

drawdown.

The Company will also seek at the next General Meeting the approval of its shareholders to change the price of all

50,242,303 existing warrants to US$0.08 per warrant and extend the expiry date to December 31, 2029, subject to

regulatory and exchange approval.

The new debt facility, together with existing cash reserves, provides funds to significantly advance the development of

the PureFlow Catheter in both Europe and the US simultaneously. The EU patent has been awarded, affording patent

protection. Each approval, if successful, increases significantly the market distribution opportunity size and scope.

The development of the PureFlowCath Catheter System in Europe will be conducted through CIC Securitisation S.A.,

domiciled in Luxembourg / EU, together with European-based providers. This will also allow the Company to apply for

grant funding offered by various European bodies.

Contacts

Mr. Robert Rhodes – Chief Executive Officer

rrhodes@innomedtec.com

www.Innomedtec.com

Innomed Tech Ltd.

Mr. Billy Williams – Director

bwilliams@innomedtec.com

The Company’s first medical device devel

I only have the original Cicc email address for Stuart can anyone direct me as to where to find new

Cheers Robdance. So they don't need the originals or your NI number? I can scan them then...Frankly I don't see any point until listing. They may never list of course.

Fingers crossed et..

I have sent pdf copy of certificate to Interactive Investor account and currently being transferred.

Had a chat with Barcs smart investor people on another matter but did ask the question re transfer. It can be done but may take some time. Good news is....No charge.

All irrelevant if not listed.

Not spoken to Barcs smart investor yet. Pointless til listed. but...According to Ai it's not that difficult to transfer. circa 30days!

"To transfer your Direct Registration System (DRS) shares from Computershare to your Barclays Smart Investor account, you must initiate the transfer through Barclays' platform. Barclays will then work with Computershare to move your shares electronically.

Step-by-Step Transfer Process

Open a Barclays Account: Ensure you have an active Barclays Smart Investor Investment Account (General Investment Account or SIPP), as you cannot lodge shares directly into an Investment ISA in this manner.

Initiate Transfer with Barclays: Log in to your Barclays Smart Investor account.

Select "Transfer In Investments" within your account.

Provide details of your current provider (Computershare) and the shares you wish to transfer.

Provide Necessary Information: You will need the following information from your Computershare statement to complete the request:

A copy of your latest DRS advice/statement.

Your Computershare Holder Account Number (starts with a 'C').

Your Taxpayer Identification Number (TIN), also known as your National Insurance number in the UK.

The exact quantity of unrestricted shares you wish to move.

Computershare's DTC number: 7807.

Ensure the name and address on both your Computershare and Barclays accounts match exactly to avoid delays.

Barclays Takes Over: For most transfers, once you provide the details and complete the online forms, Barclays will generate any necessary paperwork for you to sign and will then contact Computershare on your behalf to arrange the transfer.

Monitor the Transfer: Transfers typically take around 30 days but can vary. During this time, your shares will be frozen, and you will be unable to trade them. "

I presume other brokers will be similar. Hope this helps and hope it's not all a waste of time. Question is why go to the expense of printing and posting if it's not "imminent". Good luck all.

Good luck. Still no sign of listing...

I see unilever listed their ice cream business today, took them two or three months

Robdance. How did they transfer go? This "imminent" listing seems anything but! brings back old memories.. :)

Hiya Jim. any news from stuart? This listing seems to be taking soooo long.

Keep us informed Jim. As I said to Mac ,I cannot find a list of pending listees on TSXV. Been" imminent" for ages...

Cheers harleygreen , I have been away a few days but will speak or email Stuart and see what he says , thanks for that info .

Https://wfgplanning.com/about-billy-williams.html

Billy Williams Disclosure Officer

BWilliams@innomedtec.com

Not counting warrants..

Common shares 64,745,192

Warrants 52,942,303

Options 0

Preference shares non

So approx mac...you and I own one half of one percent of the company between us.. :)

InnoMed Tech Ltd. (the "Company"), is pleased to announce that the Company has received conditional approval from the TSX Venture Exchange ("TSXV") for the listing of its common shares (the "Shares") on the TSXV, subject to completion of requirements of the TSXV, including receipt of all required documentation within a 90-day period from May 20, 2025.

The Company has filed its final Non-offering Long Form Prospectus (the "Prospectus") with the British Columbia Securities Commission.

The Prospectus contains important information relating to the Company, its business, and the risks associated with an investment in its securities. Investors are urged to read the Prospectus, which is available under the Company's profile on SEDAR+ at www.sedarplus.ca or on the Company's Website: www.InnomedTec.com.

Rob Rhodes, CEO, stated: "We are very pleased to reach this significant milestone of TSXV conditional listing approval on the TSX Venture Exchange. This achievement reflects our commitment to creating long-term value from our patented intellectual property for our shareholders and delivering our vision of developing and bringing medical innovations to market that improve clinical outcomes.

ABOUT INNOMED TECH.

The Company is in the business of medical devices and sciences within the global medical community.

The Company's first medical device development subsidiary, PureFlowCath, LLC, is delivering the PureFlowCath Catheter System for Continuous Irrigation ("CSCI"). CSCI addresses a significant market opportunity for reducing or eliminating urinary tract infections commonly associated with the use of urinary catheters. The Company was awarded various patents, including the European Patent, and is progressing the development of the PureFlowCath Catheter System to market.

ENQUIRIES

Billy Williams billy@wfgplanning.com

www.InnomedTec.com

Transaction Advisor CIC Capital Ltd.

​

Stuart J. Bromley Bromley@CICCapital.com

I have today received another DRS advice note for another 11,000 shares .That's 16,000 in all.

That's the same as you then Mac? I guess they are worth nothing unless they list...? And still no idea of a listing sp or listing date?

BillB, did he respond?

Thanks for the info kbw. Will e-mail him.

Billb, I emailed bromley@ciccapital.com

He did respond asking who my broker was to see what communication there has been.

Hi all. I have CICC shares in my Halifax account. How do I get in touch with Stuart. Thanks in advance.

Cheers bud. Will do. There are some stranded shareholders on the General section.... Trying to bring them here but it's hard to find!

Sign up for the Innomed Newsletter......

https://www.innomedtec.com/medical-devices-new

I shall keep one eye on this to see if innomed lists... There must be a mooted listing price surely?

Two constants in my life ..cicc don't re list and spurs never win the premiership.. :(

Looks like a long way off still.. Macnai would know more than me .Been out the loop enjoying life in SouthWest.

I would imagine if CiCC ( the viable one) re lists it will in Canada in which case the same computershare letter will arrive if they have your address . The same as INNOMED.

Do we all expect to get new shares or use the same ones we have cicc?

Hello chaps! Long time no speak..(Sparty1) To my utter shock I have just received through the post a DRS (Direct registration advice) to the effect that I have 5,000 Innomed shares registered in my name via computershare.

Now I've been out the loop so long I'd forgotten.

Just to catch up ...are we listing? Really? and are these 5,000 shares worth more than a case of beer? If so I presume my broker barx can incorporate them into my investment account. Barcs now alow trade in Foreign exchanges.

Any help gratefully received.

I think they must be making more money writing prospectuses before anything else, the number ive seen and have been shared pre listing is huge

I rest my case. More silence. Where is this listing??

We have seen new websites before. Remember the CIC family ones? Then what? Nothing. Silence. Zero results on anything.

Https://www.innomedtec.com/home-new

Conditional listing approval (TSXV)

Achieved (June 10, 2025)

Filing Prospectus (British Columbia)

Completed

Fulfillment of TSXV conditions

⌛ In progress (by mid‑August 2025)

Final listing approval

Pending completion

Public trading begins

To follow final approval

So no news on listing. No update. Is anyone surprised?

Note that its CIC Group Ltd not CIC Capital Ltd but still interesting .

Https://www.linkedin.com/in/becky-zhao-bromley-4792b9171/?originalSubdomain=cn